Correction: Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers (EJNMMI Research, (2025), 15, 1, (67), 10.1186/s13550-025-01258-y)

Ruben D. Houvast*, Vincent Q. Sier, Maurice van Duijvenvoorde, Victor M. Baart, Timo Schomann, Jia Xin Chua, Mireille Vankemmelbeke, Lindy G. Durrant, Daniëlle Krijgsman, Pieter de Heer, Gert Jan Hassing, J. Sven D. Mieog, A. Stijn L.P. Crobach, Jacobus Burggraaf, Peter J.K. Kuppen, Alexander L. Vahrmeijer, Cornelis F.M. Sier

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

Following discussion between the authors and the journal, the authorship of the published article has been updated by moving Dr Cornelis F. M. Sier from the Acknowledgements to the authorship list (as the final author in the list). The reason for this post-publication correction is to acknowledge Dr Sier’s role as a primary supervisor from the early stages of the research presented in the manuscript.

Original languageEnglish
Article number117
JournalEJNMMI Research
Volume15
Issue number1
DOIs
Publication statusPublished - 2 Sept 2025

Fingerprint

Dive into the research topics of 'Correction: Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers (EJNMMI Research, (2025), 15, 1, (67), 10.1186/s13550-025-01258-y)'. Together they form a unique fingerprint.

Cite this